Author Archive: Jeremy Parkinson
US Dollar Eyes Quarles Hearing, Durables Data After FOMC-Led Drop
The US Dollar underperformed in Asian trade as regional investors took their turn to respond to what has been an FOMC policy announcement that the markets have interpreted as dovish. The Australian and New Zealand Dollars duly rose, reveling in support from yield-seeking capital flows as US Treasury yields edged down alongside the greenback. From here, a quiet European data […]
Bull Of The Day: Unilever
After many years of underperformance, emerging markets are shining in 2017. We can see signs of improving economic growth in many parts of the developing world. This rebound has benefitted multinational giants that derive a significant portion of their sales from emerging markets. About the Company Headquartered in London, UK, Unilever PLC (UL – Free Report) is a multinational […]
Deutsche Bank Tumbles After Abysmal Trading Results
Deutsche Bank shares tumbled 4% on Thursday after reporting better than expected earnings, driven by provisions and dramatic cost-cutting, more than offset however by a sharp drop in overall company revenue which slumped to the lowest in three and a half years, as Investment Banking revenue slumped 16%, while FICC tumbled a whopping 12% Y/Y […]
Strong Buy Signal: EM Valuation Gap Vs. S&P 500
Given several years of diverging returns between U.S. and emerging market (EM) equities, it should come as no surprise that EM equities currently trade at a discount to U.S. equities. The size of that discount, however, is something that we feel is not being fully appreciated by many investors. As of June 30, the MSCI Emerging […]
USD, Gold & Interest Rates: A Triangle To Watch Out For
If you spend enough time observing the market you will realize that action and reaction cause most of market movements. If you take a closer look you will see that three names seem to always appear close to each other when you read your daily market news. The US dollar, better known to traders as USD […]
EC Financials Continue To Lead US Equity Sectors For 1-Year Return
The trend remains your friend if financials have been overweighted in your portfolio. Measured by one-year performance, this sector is red hot in absolute and relative terms, based on a set of proxy ETFs. Tech is a close second for one-year sector returns. Goldman Sachs forecasts that the pair will hold on to their leadership […]
AstraZeneca Says Phase III MYSTIC Trial Did Not Meet Primary Endpoint
AstraZeneca (AZN) announced progression-free survival results for the Phase III MYSTIC trial, a randomized, open-label, multi-center, global trial of Imfinzi monotherapy or Imfinzi in combination with tremelimumab versus platinum-based standard-of-care chemotherapy in previously-untreated patients with metastatic1st-line non-small cell lung cancer. The combination of Imfinzi and tremelimumab did not meet the primary endpoint of improving PFS […]
Is This The Bubble?
As a portfolio manager, I start each morning by consuming copious amounts of a heavily caffeinated beverage and a data feed from a litany of web and blog sites. Over the last few days, as asset prices have set new records, there have been numerous articles on whether the market is currently in a bubble. Here […]
Global Stocks Hit New All Time High As Dollar Rebounds; Europe Volatile On Earnings Deluge
The levitation continues with S&P futures pointing to – what else – another higher open while European stocks swung between gains and losses on the busiest earnings days of the year (85 of the Stoxx 600 report) which has seen European pharma giant AstraZeneca plunge 15%, the most on record, after its flagship lung cancer trial Mystic […]
Copper Price Rising Sharply: Is This Bullish Or Bearish?
The price of copper has gone up strongly in recent days and weeks. The fact that many have noticed this, and that financial media are becoming ultra-bullish, is a sign of caution. Let’s take a look at the copper’s chart and do a sentiment analysis to conclude whether copper is bullish or bearish going forward. […]
